InvestorWire NewsRoom

InvestorNewsBreaks

Thursday Aug 15, 2024 - 11:57 am

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Reports on Q2 2024 Financial Results, Business Highlights

Longeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, is reporting on its second-quarter 2024 financial results, as well as key business milestones. Highlights of the report include positive data from LGNV’s phase 2a clinical trial designed to evaluate Lomecel-B(TM) in Alzheimer’s disease being presented at the Alzheimer’s Association International Conference(R) (“AAIC”); receiving both Regenerative Medicine Advanced Therapy…

Continue Reading

Thursday Aug 15, 2024 - 11:51 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, its recently in-licensed abeotaxane for the treatment of…

Continue Reading

Thursday Aug 15, 2024 - 11:35 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is reporting the financial results and operating highlights for its second quarter 2024 and six-month period, which ended June 30, 2024. Highlights of the report include a 19% increase in revenue both sequentially and year-over-year; a 31% decrease in operating…

Continue Reading

Thursday Aug 15, 2024 - 11:00 am

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today published its financial results for the second quarter ended June 30, 2024, and provided a business update. Scinai plans to host a webinar to discuss its Q2 2024 results and business update on August 20,…

Continue Reading

Thursday Aug 15, 2024 - 10:54 am

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), American West Metals Report ‘Excellent Results’ from Ongoing Drilling at Storm Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company exploring for high-grade critical and precious metal deposits in Nunavut, Canada, and Virginia, USA, and American West Metals Limited today provided an update on drilling activities at the Storm Copper Project on Somerset Island, Nunavut. According to the update, the resource delineation program is on track with multiple high-grade copper intervals confirmed by assays at…

Continue Reading

Thursday Aug 15, 2024 - 10:42 am

InvestorNewsBreaks – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) Releases Q2 2024 Financial Results Report

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that provides proprietary motor-control and complete electric propulsion system technology for e-mobility, is reporting financial results for its second quarter, the period ended June 30, 2024. Highlights of the report include record quarterly revenue of C$5.3 million with C$6.7 million at quarter end in completed units; receiving Cell Driver(R) ETL certification to UL standards, which marks the next phase of…

Continue Reading

Thursday Aug 15, 2024 - 10:13 am

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on financial and operations results for its second quarter 2024, the period that ended June 30, 2024. Highlights of the report include steady progress made toward key clinical and regulatory milestones on its HeartBeam AIMIGo(TM) System, including the 510(k) submission to the U.S. Food and…

Continue Reading

Thursday Aug 15, 2024 - 9:58 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports on Voting Results of 2024 Annual and Special Meeting of Shareholders

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is reporting on its 2024 Annual and Special Meeting of Shareholders. The meeting. According to the announcement, shareholders voted on and approved all five proposals on the agenda. Proposals included the election of four directors to the company’s board of directors; the reappointment of Davidson & Company LLP, an independent registered public accounting firm,…

Continue Reading

Thursday Aug 15, 2024 - 9:43 am

InvestorNewsBreaks – Lottery.com Inc. (NASDAQ: LTRY) Moves Forward to Finalize S&MI Ltd. Acquisition, Expand Rebranded SportLocker Brand

Lottery.com (NASDAQ: LTRY), a leading online lottery services provider, has finalized the acquisition of S&MI Ltd., the technology company behind the SportLocker brand and app; the acquisition is expected to close on Sept. 1, 2024. According to the announcement, SportLocker has been rebranded as Sports.com and is focused on becoming a digital sports entertainment platform featuring an immersive experience for sports fans around the world. The…

Continue Reading

Thursday Aug 15, 2024 - 9:34 am

InvestorNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Announces Q2 2024 Financial Results, Provides Update Showing ‘Productive’ Recent Months

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today released financial results for its second quarter ended June 30, 2024, and provided a business update. According to the update, results from the company’s completed Phase 2/3 AD study showed that buntanetap significantly improved cognition in patients with early AD. Additionally, data from…

Continue Reading

Thursday Aug 15, 2024 - 9:20 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant Therapeutic

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered a new agreement with Sever Pharma Solutions. According to the announcement, the agreement is regarding scale-up extrusion of Silo’s SP-26 dissolvable, ketamine-based, injectable implant designed for the treatment of fibromyalgia and chronic pain. The announcement also noted that Sever Pharma Solutions…

Continue Reading

Wednesday Aug 14, 2024 - 3:16 pm

InvestorNewsBreaks – Blockchain Africa Conference 2024 to Continue Decade’s Work of Propelling Africa to the Forefront of Global Blockchain Revolution

Blockchain Africa Conference, Africa’s largest and most influential blockchain event, is back, celebrating its monumental 10th anniversary. Organized by Bitcoin Events, this milestone event is where the future of Africa’s blockchain ecosystem is forged. This year marks a decade of groundbreaking innovation, transformative conversations, and game-changing solutions that are propelling Africa to the forefront of the global blockchain revolution. Attendees can look forward to an…

Continue Reading

Wednesday Aug 14, 2024 - 2:30 pm

InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Eyes Expansion into More Lucrative Markets

Golden Triangle Ventures (OTC: GTVH) recently completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. “A complete shipping, logistics and trucking operation, Cargo Management Group will be a key component in providing support for GTVH’s Lavish Entertainment division. With the acquisition completed, Golden Triangle is now focused on facilitating the company’s assumption of full ownership of the logistics operation, brokerage business,…

Continue Reading

Wednesday Aug 14, 2024 - 2:00 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. “The central theme of McEwen’s speech was…

Continue Reading

Wednesday Aug 14, 2024 - 1:37 pm

InvestorNewsBreaks – Bebuzee Inc. (BBUZ) Looking to ‘Change the Game’ via Comprehensive Digital Ecosystem

Bebuzee (OTC: BBUZ) is taking internet connectivity to a level as yet unheard of in the United States through the rollout of its time-saving communications technology. “Bebuzee’s platform takes its inspiration from multi-service applications that have become popular in Asian nations, where an enormous part of the world’s population embraces an all-in-one approach to mobile and web connectivity on an all-encompassing, self-contained commerce and communication…

Continue Reading

Wednesday Aug 14, 2024 - 1:35 pm

InvestorNewsBreaks – Greenlane Holdings Inc. (NASDAQ: GNLN) Executes $6.5M Private Placement

Greenlane Holdings (NASDAQ: GNLN) has transacted a $6.5 million private placement priced at-the-market. Greenlane operates in two segments: consumer goods and industrial goods. The company is involved in developing and distributing vape devices, cannabis accessories and lifestyle products throughout the United States, Canada, and Europe. Aegis Capital Corp. acted as exclusive placement agent for the private placement. Involved in the wealth-management and investment-banking business, Aegis…

Continue Reading

Wednesday Aug 14, 2024 - 1:28 pm

InvestorNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Given $21.00 Price Target by EF Hutton

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), recently had its price target set at $21.00. The price target was issued by Jason Kolbert from EF Hutton on August 13, 2024. At the time of the announcement, Annovis Bio was trading at $7.87. “The overall price target consensus is at $26.00 with…

Continue Reading

Wednesday Aug 14, 2024 - 1:24 pm

InvestorNewsBreaks – Lottery.com Inc. (NASDAQ: LTRY) Subsidiary Partners with Bango to Expand Reach, Launch in New Markets

Lottery.com (NASDAQ: LTRY), a leading online lottery services provider, and its subsidiary, Sports.com, are expanding their partnership with Bango PLC (AIM: BGO), (“Bango”), the global leader in subscription-bundling and digital-commerce solutions. According to the announcement, the companies will work together to expand Sports.com's reach to new markets worldwide through Bango’s extensive international distribution network. Specifically, the agreement is focused on launching Sports.com in 40 markets,…

Continue Reading

Wednesday Aug 14, 2024 - 1:21 pm

InvestorNewsBreaks – Alliance Creative Group, Inc. (ACGX) Announces Q2 2024 Financial Results

Alliance Creative Group (OTC: ACGX), a parent holding company, today released the results for the second quarter ended June 30, 2024 (“Q2 2024”). Key numbers included revenues of $159,617, gross profits of $159,617, and net income of $78,843. The total assets on the company’s balance sheet as of June 30, 2024, were $4,601,150. In addition, Alliance Creative Group ended Q2 2024 with $142,061 cash on…

Continue Reading

Wednesday Aug 14, 2024 - 1:02 pm

InvestorNewsBreaks — Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) Releases Positive Drill Results

Foremost Lithium (NASDAQ: FMST) (CSE: FAT), a North American hard-rock lithium exploration company, is reporting positive results from the completed 5,826-meter drilling campaign conducted at its Zoro Lithium Property. According to the announcement, the drilling program targeted untested mineralization at depth, southeast of Dyke 1, the company's maiden inferred resource of 1,074,567 tons at a grade of 0.91% lithium oxide (“Li2O”), with a cut-off of…

Continue Reading

Wednesday Aug 14, 2024 - 12:53 pm

InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Provides Pricing of Approximately $4M Public Offering

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced the pricing of its public offering. The offering comprises approximately $4 million of common shares and/or pre-funded warrants to purchase common shares at a public offering price of $1.70 per share (minus $0.01 per pre-funded warrant). The company plans to use the proceeds of the…

Continue Reading

Wednesday Aug 14, 2024 - 12:22 pm

InvestorNewsBreaks — Blockchain Futurist Conference Anchors Upcoming Canada Crypto Week

Blockchain Futurist Conference is the anchor event for this month’s Canada Crypto Week, a weeklong series of Web3 and artificial intelligence (“AI”) events. Blockchain Futurist Conference will be providing a central hub for the weeklong event series that includes more than 30 web3 subevents, including networking events, round table discussions, book signings, investor breakfasts and more. Canada Crypto Week is slated for Aug. 11–17, 2024, in Toronto.…

Continue Reading

Wednesday Aug 14, 2024 - 12:00 pm

InvestorNewsBreaks – Impact of Trump-Musk Conversation on Trump Media & Technology Group Corp. (NASDAQ: DJT) Stock

Trump Media & Technology Group (NASDAQ: DJT) recently faced a downturn, attributed to a public conversation between former President Donald Trump and Tesla CEO Elon Musk on the social media platform X. This event, as reported by Barrons on August 13, 2024, has seemingly influenced investor sentiment negatively, leading to a decrease in the stock’s value. Trump Media, a company that has been in the spotlight…

Continue Reading

Wednesday Aug 14, 2024 - 11:20 am

InvestorNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Provides Production Update for SASB Gas Field

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided a production update for the SASB gas field. According to the update, successful production and completion of 4 workovers at Guluc-2, South Akcakoca-2, West Akcakoca-1, and Akcakoca-3 wells on the Akcakoca Platform marks a major milestone in the…

Continue Reading

Wednesday Aug 14, 2024 - 11:02 am

InvestorNewsBreaks – Torr Metals Inc. (TSXV: TMET) Appoints Global Mining Sector Veteran to the Board of Directors

Torr Metals (TSX.V: TMET), a Vancouver-based mineral exploration company, today announced the appointment of Mr. Gordon Maxwell, P.Geo, as a new member of its Board of Directors. Gordon is a highly distinguished B.Sc. Hon. Geologist from the University of Manitoba with nearly four decades of experience across the global mining sector, holding significant leadership roles at Noranda Exploration, Xstrata, and Glencore. In addition, his contributions…

Continue Reading

Wednesday Aug 14, 2024 - 10:41 am

InvestorNewsBreaks — NextPlat Corp. (NASDAQ: NXPL), Progressive Care (RXMD) Release Q2 2024 Financial Results Showing 474% Revenue Increase

NextPlat (NASDAQ: NXPL), a global e-Commerce provider, has released record financial results for its second fiscal quarter, the period ended June 30, 2024; the results include the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD). Highlights of the report indicate the company experienced a 474% increase in consolidated Q2 revenues, which totaled $17 million, and a…

Continue Reading

Wednesday Aug 14, 2024 - 10:09 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Plans Release of Q2 2024 Financial Results, Conference Call

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) in adults), plans to release its second quarter 2024 financial results after market close today, Wednesday, August 14, 2024. In addition, the company’s management will host a conference at 5…

Continue Reading

Wednesday Aug 14, 2024 - 10:04 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update

Predictive Oncology (NASDAQ: POAI) today announced its financial and operating results for the second quarter ended June 30, 2024, and provided a corporate update. The company reported a net loss of approximately $3.2 million on total revenue of approximately $0.3 million for the quarter. In addition, it concluded Q2 2024 with $5.3 million of cash and cash equivalents, compared to $8.7 million as of December…

Continue Reading

Wednesday Aug 14, 2024 - 9:59 am

InvestorNewsBreaks – RYVYL Inc.’s (NASDAQ: RVYL) Releases Q2 2024 Financial Results, Corporate Update

RYVYL (NASDAQ: RVYL), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for the diverse international markets, is reporting on its financial results for the second quarter of 2024, or the period ended June 30, 2024. The report noted that the company’s new private and white-label licensing is expected to attract new customers, lower certain processing costs and operational…

Continue Reading

Wednesday Aug 14, 2024 - 9:57 am

InvestorNewsBreaks – Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company Update

Evofem Biosciences (OTCQB: EVFM) is reporting on its financial results and corporate update for Q2 2024; the report also included a report on the first half of 2024. Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, entered into a merger agreement with Evofem last year; the agreement was amended and restated in July 2024, with a targeted close for later…

Continue Reading

Wednesday Aug 14, 2024 - 9:20 am

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage, neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, is reporting its financial results for the first quarter 2025, or the period ended June 30, 2024. The report also included a status update on the company’s pipeline, including fasedienol for the acute treatment of social anxiety…

Continue Reading

Wednesday Aug 14, 2024 - 9:00 am

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Reports Concussion Drug Stable Across Wide Range of Temps

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, recently completed the synthesis of its ONP-002 drug batch for its upcoming planned phase 2 clinical trial. Consequently, the company is reporting that ONP-002, its lead candidate for treating concussion, is stable across a wide temperature range, thus eliminating the need for cumbersome cold storage during transport…

Continue Reading

Tuesday Aug 13, 2024 - 3:23 pm

InvestorNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Shifts Focus from Livestreaming to Generative AI

Match Group (NASDAQ: MTCH), the parent company behind some of the most popular dating apps, is undergoing a significant transformation in its business strategy. This shift involves moving away from livestreaming services to focus more on generative AI technologies. This strategic pivot comes in response to changing customer behaviors post-pandemic and the intense competition from platforms like TikTok, which have impacted the growth of livestreaming…

Continue Reading

Tuesday Aug 13, 2024 - 2:38 pm

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Announces Confirmation of Potential Commercial Grade Direct Shipping Products at Storm

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company exploring for high-grade critical and precious metal deposits in Nunavut, Canada, and Virginia, USA, today confirmed potential commercial grade Direct Shipping Products (“DSPs”) at the Storm Project on Somerset Island, Nunavut. This followed a successful metallurgical study and test work program, with DSP processing test work completed on each of the Cyclone and Chinook Deposits.…

Continue Reading

Tuesday Aug 13, 2024 - 2:03 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) KAP Orders 23 E-Phones for Installation at Leading Cancer Center

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has received a purchase order from a Knightscope Authorized Partners (“KAP”). According to the announcement, Transportation Solutions & Lighting Inc. — Safety and Security Division — National Safety Systems (“NSS/TS&L”) has ordered 23 K1 Blue Light Emergency Phones. Knightscope reported that the devices will be installed at a world-class Florida cancer…

Continue Reading

Tuesday Aug 13, 2024 - 12:37 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Report on Annual Shareholders’ Meeting Activity

Aditxt (NASDAQ: ADTX), an innovation platform dedicated to discovering, developing and deploying promising innovations, is reporting on the results of its recent annual shareholders' meeting. According to the announcement, all nine proposed agenda items were successfully passed. Those proposals include the election of directors, the ratification of auditors, and the issuing of shares for Series B-1 and B-2 convertible preferred stock.In addition, a proposed Equity Line…

Continue Reading

Tuesday Aug 13, 2024 - 11:41 am

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces ‘Exceptional Results’ in Q2 2024

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, today announced its financial results for the second quarter of 2024 (“Q2 2024”) ended June 30, 2024, and the first half of the year (year to date). According to the announcement, the results demonstrated robust growth and continued operational success. Key numbers included a 75% increase in Q2…

Continue Reading

Tuesday Aug 13, 2024 - 11:35 am

InvestorNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, is reporting on financial results and other highlights for the second quarter of 2024, the period ended June 30, 2024. According to the report, operating cash flow for the period 2024 increased 71% while operating expenses decreased 17%. In addition, the company has listed a noncore asset…

Continue Reading

Tuesday Aug 13, 2024 - 11:27 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, met with the U.S. Food and Drug Administration (“FDA”) to hold a Type B Initial Breakthrough Therapy Meeting. The meeting, which was held last week, was regarding the company’s plans to initiate its phase 3 pivotal trial of CYB003 for…

Continue Reading

Tuesday Aug 13, 2024 - 11:12 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications

Predictive Oncology (NASDAQ: POAI), a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, has expanded the available applications for its platform to account for patient heterogeneity, derisk drug discovery and accelerated pipeline development. The company announced that its findings demonstrate real-world applications of POI’s AI platform to support biomarker discovery, clinical trial optimization and target validation; the platform also offers a proprietary tool that accounts…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).